Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
Advisory Committee on Immunization Practices (ACIP) Advisory Committee on Immunization Practices (ACIP)
Advisory Committee on Immunization Practices (ACIP)

The ACIP is a group of medical and public health experts that develops recommendations on the use of vaccines in the civilian population of the United States. The ACIP holds three meetings each year at the Centers for Disease Control and Prevention (CDC), in Atlanta, Georgia to make vaccine recommendations. Meetings are open to the public and available online via webcast. More information on ACIP is available at: https://www.cdc.gov/vaccines/acip/index.html.

Narrow Results:
Publish Year
More
Genre
More
Document Type
More
Subject
More
Name as Subject
More
Place as Subject
More
    Advisory Committee on Immunization Practices (ACIP) summary report : February 24-25, 2010, Atlanta, Georgia
    Cite
    Corporate Authors:
    Description:
    File Type:
    File Type:
    ACIP COVID-19 Vaccines Work Group, December 19, 2020
    Cite
    Personal Author:
    Description:
    File Type:
    File Type:
    Overview of Moderna’s COVID-19 Vaccine (mRNA-1273)
    Cite
    Personal Author:
    Description:
    File Type:
    File Type:
    Grading of recommendations, assessment, development, and evaluation (GRADE) : Moderna COVID-19 vaccine
    Cite
    Personal Author:
    Description:
    File Type:
    File Type:
    EtR Framework : Moderna COVID-19 vaccine
    Cite
    Personal Author:
    Description:
    File Type:
    File Type:
    Anaphylaxis following m-RNA COVID-19 vaccine receipt
    Cite
    Personal Author:
    Description:
    File Type:
    File Type:
    Use of mRNA COVID-19 vaccines : interim clinical considerations
    Cite
    Personal Author:
    Description:
    File Type:
    File Type:
    ACIP COVID-19 Vaccines Work Group, December 20, 2020
    Cite
    Personal Author:
    Description:
    File Type:
    File Type:
    Phased allocation of COVID-19 vaccines
    Cite
    Personal Author:
    Description:
    File Type:
    File Type:
    Considerations for populations Included in Phase 1b and 1c
    Cite
    Personal Author:
    Description:
    File Type:
    File Type:
    BNT162b2 vaccine candidate against COVID-19
    Cite
    Personal Author:
    Description:
    File Type:
    File Type: